KFI
HZNP

Key Financial Inc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Key Financial Inc’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,195
Closed -$138K – 1367
2023
Q3 		$138K Hold
1,195
– – 0.05% 243
2023
Q2 		$123K Hold
1,195
– – 0.04% 262
2023
Q1 		$130K Hold
1,195
– – 0.05% 242
2022
Q4 		$74K Hold
1,195
– – 0.03% 303
2022
Q3 		$74K Hold
1,195
– – 0.03% 306
2022
Q2 		$97K Hold
1,195
– – 0.05% 247
2022
Q1 		$126K Hold
1,195
– – 0.06% 218
2021
Q4 		$129K Hold
1,195
– – 0.06% 200
2021
Q3 		$131K Hold
1,195
– – 0.07% 189
2021
Q2 		$120K Buy
+1,195
New +$110K 0.07% 203

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Key Financial Inc's HZNP Position: Q4 2023 in Review

Key Financial Inc sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,195 shares — an estimated $138K sold.

Key Financial Inc first reported a position in HZNP in Q2 2021 and held it in 10 quarters. The position peaked at $138K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Key Financial Inc reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Key Financial Inc sold 1,195 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $138K.
  • Key Financial Inc first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and held it in 10 quarters.
  • Key Financial Inc's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $138K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Key Financial Inc's 13F filing for Q4 2023, filed 31 Jan 2024.